Open AccessEffect of vildagliptin as add-on therapy to a low-dose metformin
Author(s) -
Claudia Filozof
Publication year - 2010
Publication title -
world journal of diabetes
Language(s) - English
Resource type - Journals
ISSN - 1948-9358
DOI - 10.4239/wjd.v1.i1.19
Subject(s) - vildagliptin , metformin , medicine , clinical endpoint , diabetes mellitus , type 2 diabetes , adverse effect , confidence interval , dipeptidyl peptidase 4 inhibitor , type 2 diabetes mellitus , gastroenterology , pharmacology , endocrinology , randomized controlled trial
To evaluate the efficacy and safety of the addition of vildagliptin to low-dose metformin and compare it to an uptitration of metformin in type 2 diabetes mellitus (T2DM) patients who have inadequate control with metformin monotherapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom